Samantha B. Kemp
Immunology and Microbiology · University of Michigan
Publications
483
Citations
3,514
Est. group size
~15
Recurring co-author estimate
Active years
23
Publishing since 2004
Typically publishes in teams of ~15 · 2% small-team papers (≤3 authors) · across 14 venues
- T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Models of Pancreatic Ductal Adenocarcinoma
Cancer Discovery · 2025
- Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy
Clinical Cancer Research · 2025
- RAS Pathway Inhibitors Combined with Targeted Agents Are Active in Patient-Derived Spheroids with Oncogenic KRAS Variants from Multiple Cancer Types
Cancer Research Communications · 2025
- Abstract 6405: T-cell dependency of tumor regressions and complete responses with RAS(ON) multi-selective inhibition in preclinical models of PDAC
Cancer Research · 2025
- Supplementary Table S1 from Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy
2025
- Supplementary Figure S7 from Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy
2025
- Supplementary Data S1 from Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy
2025
- Supplementary Figure S5 from Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy
2025
- Supplementary Figure S6 from Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy
2025
- Supplementary Figure S4 from Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy
2025
- Supplementary Figure S1 from Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy
2025
- Supplementary Figure S2 from Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy
2025
- Supplementary Figure S3 from Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy
2025
- Supplementary Figure S8 from Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy
2025
- Data from Multimetric MRI Captures Early Response and Acquired Resistance of Pancreatic Cancer to KRAS Inhibitor Therapy
2025
- Cancer Research×16
- bioRxiv (Cold Spring Harbor Laboratory)×7
- Clinical Cancer Research×4
- Zenodo (CERN European Organization for Nuclear Research)×4
- Cancer Discovery×3
- Nina G. Steele
Immunology and Microbiology · University of Michigan
- Katelyn L. Donahue
Immunology and Microbiology · University of Michigan
- Kristee Brown
Immunology and Microbiology · University of Michigan
- Daniel James Salas-Escabillas
Immunology and Microbiology · University of Michigan
- Anoop Prabhu
Immunology and Microbiology · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile